Citigroup’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$37.7K Sell
3,629
-4,079
-53% -$42.4K ﹤0.01% 4173
2025
Q1
$102K Sell
7,708
-543
-7% -$7.16K ﹤0.01% 3825
2024
Q4
$148K Buy
8,251
+3,034
+58% +$54.3K ﹤0.01% 3785
2024
Q3
$84.1K Buy
5,217
+3,645
+232% +$58.8K ﹤0.01% 4073
2024
Q2
$42.5K Buy
1,572
+845
+116% +$22.8K ﹤0.01% 3949
2024
Q1
$14.2K Buy
727
+82
+13% +$1.6K ﹤0.01% 4367
2023
Q4
$13.3K Buy
645
+584
+957% +$12.1K ﹤0.01% 4361
2023
Q3
$1.94K Sell
61
-1,179
-95% -$37.4K ﹤0.01% 4212
2023
Q2
$41.6K Sell
1,240
-5,122
-81% -$172K ﹤0.01% 4059
2023
Q1
$265K Sell
6,362
-3,760
-37% -$157K ﹤0.01% 2952
2022
Q4
$343K Buy
10,122
+9,660
+2,091% +$327K ﹤0.01% 2753
2022
Q3
$23K Buy
462
+257
+125% +$12.8K ﹤0.01% 3978
2022
Q2
$8K Sell
205
-71
-26% -$2.77K ﹤0.01% 4707
2022
Q1
$10K Sell
276
-641
-70% -$23.2K ﹤0.01% 4758
2021
Q4
$90K Sell
917
-2,833
-76% -$278K ﹤0.01% 4022
2021
Q3
$468K Buy
3,750
+3,353
+845% +$418K ﹤0.01% 2941
2021
Q2
$50K Sell
397
-4,214
-91% -$531K ﹤0.01% 4155
2021
Q1
$626K Buy
4,611
+4,044
+713% +$549K ﹤0.01% 2682
2020
Q4
$52K Buy
567
+432
+320% +$39.6K ﹤0.01% 4079
2020
Q3
$10K Sell
135
-193
-59% -$14.3K ﹤0.01% 4328
2020
Q2
$28K Sell
328
-5,080
-94% -$434K ﹤0.01% 4043
2020
Q1
$391K Buy
5,408
+5,381
+19,930% +$389K ﹤0.01% 2428
2019
Q4
$2K Sell
27
-67
-71% -$4.96K ﹤0.01% 5003
2019
Q3
$5K Sell
94
-211
-69% -$11.2K ﹤0.01% 4796
2019
Q2
$16K Sell
305
-54
-15% -$2.83K ﹤0.01% 4643
2019
Q1
$25K Buy
359
+167
+87% +$11.6K ﹤0.01% 4425
2018
Q4
$16K Buy
192
+17
+10% +$1.42K ﹤0.01% 4494
2018
Q3
$82K Buy
175
+165
+1,650% +$77.3K ﹤0.01% 3727
2018
Q2
$4K Sell
10
-71
-88% -$28.4K ﹤0.01% 4784
2018
Q1
$24K Buy
81
+77
+1,925% +$22.8K ﹤0.01% 4138
2017
Q4
$1K Buy
+4
New +$1K ﹤0.01% 4900
2017
Q3
Sell
-4
Closed -$3K 4834
2017
Q2
$3K Sell
4
-3
-43% -$2.25K ﹤0.01% 4460
2017
Q1
$3K Buy
+7
New +$3K ﹤0.01% 4589
2016
Q4
Sell
-14
Closed -$6K 4940
2016
Q3
$6K Buy
+14
New +$6K ﹤0.01% 4602